What is the primary mechanism of action of Prazosin?

What is the primary mechanism of action of Prazosin?

• A. Inhibition of beta-adrenergic receptors
• B. Competitively inhibits postsynaptic alpha 1-adrenergic receptors
• C. Blocking calcium channels in cardiac muscle
• D. Agonizing beta-2 adrenergic receptors

Answer: (B)

Prazosin primarily works by competitively inhibiting postsynaptic alpha 1-adrenergic receptors. This action leads to the relaxation of vascular smooth muscle, resulting in vasodilation and a subsequent decrease in blood pressure. By blocking these receptors, Prazosin effectively counters the effects of norepinephrine, which would normally promote vasoconstriction and increase peripheral resistance. As a result, the drug is commonly used to treat hypertension and can also aid in the management of symptoms associated with benign prostatic hyperplasia due to its effects on smooth muscle tone in the bladder and prostate. The other mechanisms described, such as inhibition of beta-adrenergic receptors, blocking calcium channels, or agonizing beta-2 adrenergic receptors, do not apply to Prazosin and are characteristic of other drugs. Understanding how Prazosin operates within the adrenergic system is vital for recognizing its therapeutic applications and potential side effects in patients.

Prazosin primarily works by competitively inhibiting postsynaptic alpha 1-adrenergic receptors. This action leads to the relaxation of vascular smooth muscle, resulting in vasodilation and a subsequent decrease in blood pressure. By blocking these receptors, Prazosin effectively counters the effects of norepinephrine, which would normally promote vasoconstriction and increase peripheral resistance. As a result, the drug is commonly used to treat hypertension and can also aid in the management of symptoms associated with benign prostatic hyperplasia due to its effects on smooth muscle tone in the bladder and prostate.

The other mechanisms described, such as inhibition of beta-adrenergic receptors, blocking calcium channels, or agonizing beta-2 adrenergic receptors, do not apply to Prazosin and are characteristic of other drugs. Understanding how Prazosin operates within the adrenergic system is vital for recognizing its therapeutic applications and potential side effects in patients.